The Recall Desk
Agency classClass IIOur severity:HighFDA (Drugs)·D-0362-2022·Announced 2022-01-19

Metoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets

Rubicon Research Private Limited is recalling Metoprolol Tartrate 25 mg tablets (batch #210211H1, expiration February 2024) due to a complaint of metal embedded in a tablet.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall involving a physical contaminant (metal) that poses an immediate risk of harm to patients who ingest the affected tablets. Although no illnesses or injuries have been reported, the presence of foreign metal in a consumable drug product creates a direct hazard that warrants a High severity rating under the rubric criteria for risk-of-harm products.

Plain-English summary

Rubicon Research Private Limited is recalling Metoprolol Tartrate Tablets, USP 25 mg, supplied in 1000-count bottles (NDC 52817-360-00 and other NDCs) distributed by TruPharma, LLC. The recall was initiated after a complaint was received reporting foreign metal matter embedded in a tablet.

The affected batch is #210211H1 with an expiration date of February 2024. A total of 3,684 bottles of 1000-count product were distributed through one distributor, which may have distributed the product further nationwide.

Consumers who have this product should stop using it immediately and contact their pharmacist or healthcare provider. Patients taking this medication should not stop their regimen without medical guidance but should obtain a replacement from their pharmacy or physician.

The recalled product

Product
METOPROLOL TARTRATE (METOPROLOL TARTRATE)
Brand
METOPROLOL TARTRATE

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Batch # 210211H1
  • Exp. date FEB 2024

UPCs (10)

  • 0352817361103
  • 0352817361004
  • 0352817360106
  • 0352817362100
  • 0352817358509
  • 0352817359506
  • 0352817362001
  • 0352817360007
  • 0352817358103
  • 0352817359100

Distribution

Distributed nationwide across the United States.

Same brand · METOPROLOL TARTRATE

Same manufacturer · Rubicon Research Private Limited

See all →

Similar recalls